COTINGA PHARMACEUTICALS
Critical Outcome Technologies Inc. (COTI) believes that there must be a better way to get safe and effective new drug therapies to people in need on a more timely, cost effective and efficient manner. Their business is disease-specific drug discovery, optimization and pre-clinical development using a specially developed series of computer models. COTI is focused on the discovery and pre-clinical development of small molecules for the treatment of serious diseases for which current therapy is either lacking or ineffective.
COTINGA PHARMACEUTICALS
Industry:
Biotechnology Developer Platform Ediscovery Medical Pharmaceutical
Founded:
1999-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.cotingapharma.com
Total Employee:
11+
Status:
Active
Contact:
1-800-798-8680
Email Addresses:
[email protected]
Total Funding:
4.24 M USD
Technology used in webpage:
Domain Not Resolving
Similar Organizations
NMD Pharma
NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.
Current Employees Featured
Founder
Stock Details
Official Site Inspections
http://www.cotingapharma.com
- Host name: ip-70.32.1.32.hosted.by.gigenet.com
- IP address: 70.32.1.32
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Cotinga Pharmaceuticals"
Cotinga Pharmaceuticals - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 1-800-798-8680 Critical Outcome Technologies Inc. (COTI) believes that there must be a better way to get safe and effective …See details»
Cotinga Pharmaceuticals Inc | LinkedIn
Cotinga Pharmaceuticals Inc, formerly Critical Outcome Technologies Inc (COTI) is a Canada-based clinical-stage biopharmaceutical company. The Company's artificial intelligence …See details»
Cotinga Pharmaceuticals - Craft
Cotinga Pharmaceuticals is a biopharmaceutical company focused on developing treatments for a range of cancers by targeting the mechanisms driving cancer cell survival.See details»
Cotinga Pharmaceuticals Inc - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Cotinga Pharmaceuticals Inc of London, ON. Get the latest business insights from Dun & Bradstreet.See details»
Critical Outcome Technologies Changes Name to Cotinga …
Jan 8, 2018 About Cotinga Pharmaceuticals Inc. Cotinga Pharmaceuticals is a clinical-stage pharmaceutical company that uses proprietary artificial intelligence technologies to develop …See details»
Cotinga Pharmaceuticals - Company info. interviews, news
Cotinga Pharmaceuticals (COT.V) (formerly “Critical Outcome Technologies Inc.”) is a biopharmaceutical company focused on developing treatments for a broad range of cancers …See details»
Cotinga Pharmaceuticals - PitchBook
Cotinga Pharmaceuticals General Information Description. Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is …See details»
www.cotingapharma.com
Www.cotingapharma.comSee details»
Cotinga Pharmacueticals Provides Scientific and Business
Mar 19, 2019 Email: [email protected] Notice to Readers: Information contained in this press release may contain certain statements which constitute “forward-looking …See details»
Cotinga Pharmaceuticals Inc. | Insights
Jun 4, 2019 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Cotinga Pharmaceuticals DMF, CEP, Written Confirmations, FDF, …
Cotinga Pharmaceuticals// Cotinga Pharmaceuticals (COT.V) (formerly “Critical Outcome Technologies Inc.”) is a biopharmaceutical company focused on developing treatments for a …See details»
Cotinga Pharmaceuticals Inc. Stock Other OTC - MarketScreener.com
Jun 17, 2011 Cotinga Pharmaceuticals Inc is a Canada-based clinical-stage biopharmaceutical company. The Company's artificial intelligence platform, CHEMSAS, utilizes a series of …See details»
Cotinga Pharmaceuticals Releases Early Interim Data of
May 8, 2019 Email: [email protected] Notice to Readers: Information contained in this press release may contain certain statements which constitute “forward-looking statements” as …See details»
Cotinga Pharmacueticals Announces Closing of Second Tranche
TORONTO and BOSTON, June 04, 2019 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture: COT) (“Cotinga” or the “Company”), a clinical stage biopharmaceutical …See details»
Cotinga Pharmaceuticals Ord Shs
Get the latest Cotinga Pharmaceuticals Ord Shs (COTQF) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment …See details»
Cotinga Pharmaceuticals Announces Research Partnership with
Nov 5, 2018 Email: [email protected] Notice to Readers: Information contained in this press release may contain certain statements which constitute “forward-looking statements” as …See details»
Cotinga Pharmaceuticals, Inc. (Cotinga Pharmaceuticals, Inc.) - 药 …
了解Cotinga Pharmaceuticals, Inc. (Cotinga Pharmaceuticals, Inc.)公司的药物管线，治疗领域，技术平台，以及它的1项临床试, 5篇新闻和2篇文献，疾病领域:肿瘤，技术平台:小分子化 …See details»
Cotinga Pharmaceuticals Announces Initiation of Next Cohort
Jun 5, 2019 Email: [email protected] Notice to Readers: Information contained in this press release may contain certain statements which constitute “forward-looking statements” as …See details»
Cotinga Pharmaceuticals Doses First Patient in Third Cohort
Jun 27, 2019 Email: [email protected] Notice to Readers: Information contained in this press release may contain certain statements which constitute “forward-looking statements” as …See details»